Systemic review and meta-analysis: 10-day or 14-day sequential therapy versus 14-day triple therapy in the first line treatment of Helicobacter pylori infection

被引：0

作者：

Kuo, Chia-Chi ^{[1
]}

Liou, Jyh-Ming ^{[1
]}

Chen, Chieh-Chang ^{[1
]}

Lee, Yi-Chia ^{[1
]}

Chen, Mei-Jyh ^{[1
]}

Wu, Ming-Shiang ^{[1
]}

机构：

[1] Natl Taiwan Univ, Coll Med, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei, Taiwan

来源：

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2015年 / 30卷

关键词：

duration; clarithromycin; metronidazole; resistance; efficacy;

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1816

引用

页码：130 / 130

页数：1

共 50 条

[41] Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea
Kim, Y. S.
Kim, S. J.
Yoon, J. H.
Suk, K. T.
Kim, J. B.
Kim, D. J.
Kim, D. Y.
Min, H. J.
Park, S. H.
Shin, W. G.
Kim, K. H.
Kim, H. Y.
Baik, G. H.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (09) : 1098 - 1105
[42] COMPARISON OF 7-DAY AND 14-DAY TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION AND CHANGE OF ERADICATION RATE
Lee, S.
Yang, C.
HELICOBACTER, 2012, 17 : 103 - 103
[43] BOTH 14-DAY VONOPRAZAN TRIPLE THERAPY AND 14-DAY RABEPRAZOLE REVERSE HYBRID THERAPY ARE SUPERIOR TO 14-DAY VONOPRAZAN HIGH-DOSE DUAL THERAPY FOR THE FIRST-LINE ANTI-H. PYLORI TREATMENT IN POPULATION WITH HIGH RATES OF ANTIBIOTIC RESISTANCE
Hsu, Ping-I
Shih, Chih-An
Chen, Chien-Lin
Chuah, Seng-Kee
Yang, Jyh-Chin
Wu, Deng-Chyang
GASTROENTEROLOGY, 2024, 166 (05) : S431 - S431
[44] 14-day sequential therapy versus 10-day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicenter, non-inferiority, randomized trial
Chen, Po-Yueh
Chen, Mei-Jyh
Fang, Yu-Jen
Lin, Jaw-Town
Wu, Ming-Shiang
Liou, Jyh-Ming
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 358 - 358
[45] Efficacy of 7-day bismuth-based quadruple therapy versus 14-day moxifloxacin-based triple therapy for second-line treatment of Helicobacter pylori infection
Kim, Sung Eun
Roh, Ji Hun
Park, Moo In
Park, Seun Ja
Moon, Won
Kim, Jae Hyun
Jung, Kyoungwon
Seo, Kwang Il
Lee, Young Dal
Seol, Sang Young
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 63 - 63
[46] Economic analysis and outcomes of 10-day sequential therapy compared to 10-day triple therapy for Helicobacter pylori (H pylori) eradication
Vakil, Nimish
Zullo, Angelo
Ricci, Chiara
Vaira, Dino
GASTROENTEROLOGY, 2008, 134 (04) : A619 - A619
[47] EFFICACY OF 7-DAY BISMUTH-BASED QUADRUPLE THERAPY VERSUS 14-DAY MOXIFLOXACIN-BASED TRIPLE THERAPY FOR SECOND-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION
Kim, Sung Eun
Roh, Ji Hun
Park, Moo In
Park, Seun Ja
Moon, Won
Kim, Jae Hyun
Jung, Kyoungwon
Jeong, Joonho
GASTROENTEROLOGY, 2017, 152 (05) : S248 - S248
[48] Comparative Efficacy of 14-Day Tegoprazan-Based Triple vs. 10-Day Tegoprazan-Based Concomitant Therapy for Helicobacter pylori Eradication
Park, Chan Hyuk
Song, Myung Jin
Jung, Byung Wook
Park, Jung Ho
Jung, Yoon Suk
JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (11):
[49] Success of 14-day triple and quadruple therapy for the control of Helicobacter pylori infections in Kohat district
Shah, Syed Fahim
Paracha, Sohail Aziz
Ullah, Waheed
Muhammad, Iqbal
Iqbal, Somaid
Gul, Aisha
Hussain, Mudassir
Ullah, Hafiz
Zaman, Sadir
DRUG TARGET INSIGHTS, 2022, 16 : 49 - 53
[50] Efficacy of 10-day VAL (Vonoprazan, Amoxicillin, and Levofloxacin) vs 14-day Standard Triple Therapy for Helicobacter pylori Eradication: A Multicenter Randomized Controlled Trial
Sangsuwan, Suttigiat
Suksamai, Anuchit
Preechathammawong, Noppamate
Songserm, Sukhum
Opuchar, Krit
Chirapongsathorn, Sakkarin
Yongwatana, Kachonsak
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1621 - S1622

← 1 2 3 4 5 →